PRESCRIBING · PART D · 2024
Total Rx claims
452
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
13
Brand share
90.3%
Top prescribed drugs
Dolutegravir Sodium113 claims
Bictegrav/Emtricit/Tenofov Ala105 claims
Emtricitabine/Tenofov Alafenam75 claims
Emtricitab/Rilpiviri/Tenof Ala28 claims
Raltegravir Potassium22 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE